Health Populi

Monday, May 5, 2008

The virtues of virtual visits


There is more evidence that remote health care can improve health outcomes. Say 'hello' to the Virtual Integrated Practice (VIP).

The term was coined by the Rush-Presbyterian Medical Center, where a team has been refining the VIP model for the past four years. The VIP's objective is to improve chronic disease management for older people by deploying an
interdisciplinary team using communications technology.

The main challenges in primary care for VIP's target patient population are:

• Multiple chronic problems
• Polypharmacy
• Physical disability
• Functional impairment, and
• Economic stressors.

The Holy Grail here is that when these patients are optimally-managed, VIP can identify missed opportunities for primary prevention and avoid eventual disability.


As the population ages, more chronic conditions ensue. Traditional institutionally-based care in hospitals and nursing homes is based on synchronous, face-to-face care. VIP disrupts that institutional model, instead embracing a team-based, asynchronous co-located model. Clinicians on the patients' team interact in the medical record and enhance ongoing team communication about the patient's progress.

The VIP team consists of a nurse, a social worker/case manager, a physician, a pharmacist, and a physical therapist. Here's the 'co-located' part: they're in different settings, and they relate to the patient at different times. But they're coordinated via information technology -- the electronic patient record.

One of the most important lessons the team learned in its four-year study is that patients expect the professionals on care teams to communicate with each other. This is typically not a streamlined, efficient or effective process in traditional primary care.

Toolkits are available here for several health issues: diabetes, nutrition, urinary incontinence/overactive bladder.

The study is funded by the John Hartford Foundation of New York.

Health Populi's Hot Points: The critical success factor with VIP is that the patient is at the center of the process. The team emphasizes self-management training in all interactions, and establishes monitor-able goals throughout the encounters. Messages are triggered to team members and to adjacent professionals as needed, which may include a nutritionist, an ophthalmology, or a podiatrist, for example. With the patient as an integral member of the virtual team, outcomes are improved. It's not about the technology per se -- which clearly enables this concept -- it's the process: the right caregiver at the right time using the right technology.

1 Comments:

  • A study finds that common drugs hasten decline in elderly -- which relates to the polypharmacy challenge in managing chronic disease in older adults:
    Sat May 3, 2008
    Reuters
    Elderly people who took commonly prescribed drugs for incontinence, allergy or high blood pressure walked more slowly and were less able to take care of themselves than others not taking the drugs, U.S. researchers said on Saturday.
    They said people who took drugs that block acetylcholine -- a chemical messenger in the nervous system critical for memory -- functioned less well than their peers.
    "These results were true even in older adults who have normal memory and thinking abilities," said Dr. Kaycee Sink of Wake Forest University School of Medicine in North Carolina, who led the study of 3,000 people of whom 40 percent were taking more than one anticholinergic drug.
    "The effect is essentially that of a three- to four-year increase in age. So someone who is 75 in our study and taking at least one moderately anticholinergic medication is at a similar functional level to a 78 to 79-year-old," Sink said in an e-mail.
    Sink's findings, presented at American Geriatrics Society Meeting in Washington, add to a growing body of research that suggests these so-called anticholinergic medications can hasten functional and cognitive declines in elderly people.
    Some of the most common such drugs in the study included the blood pressure drug nifedipine (sold as Adalat or Procardia), the stomach antacid ranitidine or Zantac, both with mild or moderate anticholinergic properties, and Pfizer Inc's incontinence drug tolterodine or Detrol, which is highly anticholinergic.
    "The tricky part ... is that many useful drugs from many different classes of medications have anticholinergic properties," Sink said.
    She said in many cases newer drugs are available that do not have these effects and said doctors should look out for them for elderly patients.
    MEMORY DECLINE
    Dr. Jack Tsao, a neurologist with the U.S. Navy, reported last month at a American Academy of Neurology meeting that elderly people who took anticholinergic drugs had a 50 percent greater rate of memory decline than people in a long-term study who did not take the drugs.
    Sink studied the effects of taking multiple anticholinergic drugs on walking speed, basic activities such as dressing, eating, taking care of personal hygiene, grooming, and harder activities like shopping, cooking and managing money on her test subjects whose average age was 78.
    The researchers found that the more anticholinergic drugs people had in their systems, the worse their physical function, based on reports from people in the study and on independent measures of their performance.
    In a separate study this month in the Journal of the American Geriatrics Society, Sink found that older nursing home residents who took drugs for dementia and incontinence at the same time had a 50 percent faster decline in function than those treated only for dementia.
    "I would encourage patients to bring in a list of everything they take (even over-the-counter medications) to their doctor and have them review it at least yearly," Sink said. "Physicians should try to decrease anticholinergic burden whenever possible."

    By Blogger Jane Sarasohn-Kahn, At May 5, 2008 11:19 AM  

Post a Comment



<< Home